Anavex Life Sciences Corp (AVXL)

[Investor2014]

Wasn’t missing. I said all along that Anavex have ways of navigating the imperfect A2-73 Plus patent protected only in the US and the lack of standalone patent for the original A2-73 formulation.

That navigation includes market exclusivity granted by the FDA and likely other agencies around the world.

Folks just seem frustrated about the IP risk as stated in every 10-K and don’t read before writing lots angry posts.

Pathetic.